Medicine
Tigecycline 50 mg/10 mL powder for injection
Tigecycline 50 mg/10 mL powder for injection is a generic prescription medicine for intravenous, parenteral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Supplied: NDC 0781-3481-95 box of ten 50 mg 5 mL vials NDC 0781-3481-92 box of…
Key facts
- Active ingredient (INN)
- Tigecycline
- Brand
- Sold under the generic name
- Strength
- 50 mg/10 mL
- Dosage form
- Powder for injection
- Route
- Intravenous, parenteral
- Packs
- 10 vials
- Manufacturer
- Sandoz
- Origin register
- US FDA, United States
- Storage
- Supplied: NDC 0781-3481-95 box of ten 50 mg 5 mL vials NDC 0781-3481-92 box of ten 50 mg 10 mL vials Prior to reconstitution, tigecycline should be stored at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01AA12 Tigecycline
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 November 2017
- Identifiers
- RxCUI 581531DailyMed set ID 50605463-2dc2-4b27-bc51-4d87bb9a8539NDC 0781-3481Application ANDA091620
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 0781-3481-92 | Sandoz | 30 November 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Tigecycline
Clinical summary
Tigecycline is a tetracycline-class antibacterial indicated in patients 18 years of age and older for complicated skin and skin structure infections, among other approved uses. It is available as powder for injection for intravenous and parenteral use. MedsAcross supplies Tigecycline for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TigecyclineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Tygacil prescribing information (Wyeth Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Tygacil: European public assessment report (EPAR) · European Medicines Agency
- Tigecycline Accord: European public assessment report (EPAR) · European Medicines Agency
Need Tigecycline 50 mg/10 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.